Researchers dig through health records to map rare heart disease
NCT ID NCT07494656
Summary
This study looks back at existing German health insurance records to better understand ATTR-CM, a rare and serious heart condition. Researchers will analyze data from people diagnosed between 2020 and 2022 to learn about their survival rates, hospital visits, and how common the disease is. No new treatments are being tested; the goal is to gather real-world information to improve future care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTR-CM (TRANSTHYRETIN AMYLOID CARDIOMYOPATHY) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.